UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy

Cancer, 1996-06, Vol.77 (12), p.2622-2629

1996

Volltextzugriff (PDF)

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies

Journal of clinical oncology, 1993-03, Vol.11 (3), p.499-506

1993

Volltextzugriff (PDF)

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

The Journal of immunology (1950), 1986-09, Vol.137 (5), p.1735

1986

Volltextzugriff (PDF)

Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer

Journal of clinical oncology, 1991-08, Vol.9 (8), p.1462-1466

1991

Volltextzugriff (PDF)

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

The New England journal of medicine, 1985-12, Vol.313 (23), p.1485

1985

Volltextzugriff (PDF)

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2

The Journal of immunology (1950), 1985-10, Vol.135 (4), p.2865

1985

Volltextzugriff (PDF)

Increased Vascular Permeability in Organs Mediated by the Systemic Administration of Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 in Mice

JNCI : Journal of the National Cancer Institute, 1988-04, Vol.80 (3), p.177-188

1988

Volltextzugriff (PDF)

Hematologic Effects of Immunotherapy With Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 in Cancer Patients

Blood, 1987-06, Vol.69 (6), p.1654-1660

1987

Volltextzugriff (PDF)

Collagenous Colitis, Eosinophilic Colitis, and Neutropenic Colitis

The Surgical clinics of North America, 1993-10, Vol.73 (5), p.993-1016

Ettinghausen, Stephen E.

1993

Volltextzugriff (PDF)

Clinical effects and toxicity of interleukin‐2 in patients with cancer

Cancer, 1986-12, Vol.58 (12), p.2764-2772

1986

Volltextzugriff (PDF)

Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells

The Journal of immunology (1950), 1985-11, Vol.135 (5), p.3623

1985

Volltextzugriff (PDF)

Evolving strategies for the treatment of adenocarcinoma of the pancreas : a review

Journal of clinical gastroenterology, 1995-07, Vol.21 (1), p.48-60

1995

Volltextzugriff (PDF)

Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues

The Journal of immunology (1950), 1985-08, Vol.135 (2), p.1488

1985

Volltextzugriff (PDF)

Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2

Cancer research (Chicago, Ill.), 1986-06, Vol.46 (6), p.2784-2792

1986

Volltextzugriff (PDF)

Phase I Trial of Recombinant Human Macrophage Colony-Stimulating Factor Administered by Continuous Intravenous Infusion in Patients With Metastatic Cancer

JNCI : Journal of the National Cancer Institute, 1994-01, Vol.86 (1), p.39-45

1994

Volltextzugriff (PDF)

Pseudomyxoma peritonei syndrome

Advances in surgery (Chicago), 1996, Vol.30, p.233

1996

Volltextzugriff (PDF)

Postoperative complications in patients receiving suramin therapy

Surgery, 1994-07, Vol.116 (1), p.90-95

1994

Volltextzugriff (PDF)

Effect of corticosteroid on the antitumor activity of lymphokine-activated killer cells and interleukin 2 in mice

Cancer research (Chicago, Ill.), 1986-11, Vol.46 (11), p.5618-5623

1986

Volltextzugriff (PDF)

Inflammatory myofibroblastic tumors

Annals of surgical oncology, 2004-02, Vol.11 (S2), p.S120-S120

2004

Volltextzugriff (PDF)

Localization of an occult insulinoma by intraoperative ultrasonography

Surgery, 1985-03, Vol.97 (3), p.381-384

1985

Volltextzugriff (PDF)

The development of gene therapy for the treatment of cancer

Annals of surgery, 1993-10, Vol.218 (4), p.455-464

1993

Volltextzugriff (PDF)

Immunotherapy and gene therapy of cancer

Advances in surgery (Chicago), 1995, Vol.28, p.223-254

1995

Volltextzugriff (PDF)

The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2

Springer seminars in immunopathology, 1986-05, Vol.9 (1), p.51-71

1986

Volltextzugriff (PDF)

Adjuvant hyperthermic intraperitoneal chemotherapy for adenocarcinoma of the pancreas

Cancer treatment and research, 1996, Vol.81, p.227

1996

Volltextzugriff (PDF)

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy

Cancer research (Chicago, Ill.), 1986-02, Vol.46 (2), p.676-683

1986

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(28)
Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Female
(22)
Adult
(17)
Male
(17)
Middle Aged
(14)
Aged
(12)
Animals
(10)
Biological And Medical Sciences
(10)
Oncology
(10)
Killer Cells, Natural - Immunology
(9)
Medical Sciences
(9)
Mice
(9)
Interleukin-2 - Administration & Dosage
(7)
Surgery
(7)
Art Exhibitions
(6)
Art Museums
(6)
Bronzes
(6)
Curators
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2

Increased Vascular Permeability in Organs Mediated by the Systemic Administration of Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 in Mice

Hematologic Effects of Immunotherapy With Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 in Cancer Patients

Collagenous Colitis, Eosinophilic Colitis, and Neutropenic Colitis

Clinical effects and toxicity of interleukin‐2 in patients with cancer

Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells

Evolving strategies for the treatment of adenocarcinoma of the pancreas : a review

Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues

Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2

Phase I Trial of Recombinant Human Macrophage Colony-Stimulating Factor Administered by Continuous Intravenous Infusion in Patients With Metastatic Cancer

Pseudomyxoma peritonei syndrome

Postoperative complications in patients receiving suramin therapy

Effect of corticosteroid on the antitumor activity of lymphokine-activated killer cells and interleukin 2 in mice

Inflammatory myofibroblastic tumors

Localization of an occult insulinoma by intraoperative ultrasonography

The development of gene therapy for the treatment of cancer

Immunotherapy and gene therapy of cancer

The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2

Adjuvant hyperthermic intraperitoneal chemotherapy for adenocarcinoma of the pancreas

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy

Suchergebnisse filtern